Result Page 3 for Lymphoma news & latest pictures from ibtimes.com

Smoking linked to non-melanoma skin cancer in women

Pfizer-Drug Xalkori Approved for Lung Cancer, but at What Cost?

New York City-based Pfizer Inc. gained FDA approval for their drug Xalkori, the first new medicine in several years for deadly, advanced lung cancer, according to new research.

Doctors Report Improving Prediction of Cancer Survival Rates

A new prognostic model may predict whether patients with advanced cancer are likely to survive for days, weeks or months, researchers say.

FDA Approves Xalkori, a Pfizer Lung Cancer Drug

Xalkori is a Pfizer drug, and it works by targeting specific genes found certain patients. This gene is called the abnormal anaplastic lymphoma kinase (ALK) gene and is present in about 1 to 7 percent of non-small cell lung cancer patients.

Global drug sales seen nearing $890 bln in 2011

Experts Dispute Use of Illegal Party Drug Ecstasy to Cure Cancer

Scientists from the University of Birmingham found that a modified form of Ecstasy (MDMA) could be used in treating melanoma, lymphoma, and leukemia, after scientists modified the drug to increase its tumor-killing properties.

Insight

More news

Seattle Genetics: FDA Panel Endorses Lymphoma Drug

A government advisory panel unanimously approved an experimental drug, Adcetris, from Bothell, WA.-based drug maker, Seattle Genetics, serving as the company's first commercial drug approved by the U.S. Food and Drug Administration.

Pre-Market NASDAQ Movers (AERL, GOOG, SCEI, VICL, CRZO, SGEN, QLIK, LOGI, ICGN, COCO)

The top pre-market NASDAQ Stock Market gainers are: Asia Entertainment & Resources, Google, Sino Clean Energy, Vical, and Carrizo Oil & Gas. The top pre-market NASDAQ Stock Market losers are: Seattle Genetics, Qlik Technologies, Logitech International, ICAgen, and Corinthian Colleges.

Post-Market NASDAQ Movers (GOOG, VICL, AERL, EXTR, RECN, FLIR, LPHI, SGEN, VALV, XRTX)

The top after-market NASDAQ Stock Market gainers are: Google, Vical, Asia Entertainment & Resources, Extreme Networks, and Resources Connection. The top after-market NASDAQ Stock Market losers are: FLIR Systems, Life Partners Holdings, Seattle Genetics, Shengkai Innovations, and Xyratex.

A laboratory worker checks silicone for implants in Rio de Janeiro, in a file photo.

FDA: Silicone-gel Breast Implants Relatively Safe

FDA follow-up study on silicone-gel breast implants returned to market for patients in 2006 concludes they are safe, but won't last forever.

List Of Victims Killed In 9/11 Attacks Grows By 1

A man who died last year of lung disease while inhaling toxic debris when the World Trade Center collapsed has been added to the list of victims killed in the Sept. 11 attacks, the New York City Chief Medical Examiner's office said on Friday.

'Alice Bucket List' is Trending on Twitter; 15-year old has terminal cancer

Dying wish is to 'make everyone sign up to be a bone marrow donor'

Three ways to avoid mobile radiation

The microwave radiations emitted through mobiles phones might cause cancer a warning issued for the first time by the World Health Organization (WHO). The UN health body has listed risks that were quite alarming since it affects the youngsters and children, the most.

A participant holds a photo of former Bosnian Serb military commander Ratko Mladic during a rally to protest against the arrest of Mladic in front of the Serbian embassy in Moscow

Mladic Was Treated For Cancer In Serbia: Lawyer

A lawyer for accused war criminal Ratko Mladic claim their client was treated for cancer in a hospital in Belgrade Serbia two years ago, ahead of his first appearance in a UN court at The Hague in The Netherlands.

How do you spend $13 billion in Microsoft co-founder Paul Allen style? [SLIDESHOW]

A slideshow which showcases Microsoft co-founder and billionaire Paul Allen's many indulgences:

The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland

Roche's Rituxan drug gets FDA OK to treat rare disorders

Roche Holding AG's arthritis and cancer drug, Rituxan, received approval from the U.S. Food and Drug Administration (FDA) to treat two rare disorders that cause blood vessel inflammation.

EPA's draft health assessment for formaldehyde needs improvement (FULL TEXT)

A U.S. Environmental Protection Agency draft assessment of the potential health effects associated with formaldehyde exposure needs substantial revision, says a new report from the National Research Council, which recommends improvements for EPA's final assessment.

Spectrum Pharma Shares Hit New High on Q4 Results

Shares of Spectrum Pharmaceuticals, Inc. (SPPI) touched a new 52-week high of $7.60 on Thursday. The company posted a decline in fourth quarter earnings as last year period recorded stock warrant gains, but came ahead of Street view.

Pre-Market NASDAQ Movers (ZSTN, FLOW, SPRD, ALTH, GIII, CERS, ERII, MRVL, EVEP, WPPGY)

The top pre-market NASDAQ stock market gainers are: ZST Digital Networks, Flow International, Spreadtrum Communications, Allos Therapeutics, and G-III Apparel Group. The top pre-market NASDAQ stock market losers are: Cerus, Energy Recovery, Marvell Technology Group, EV Energy Partners, and WPP.

Post-Market NASDAQ Movers (SPRD, INVE, ALTH, FLOW, SPMD, ERII, MRVL, HILL, BSQR, EVEP)

The top after-market NASDAQ stock market gainers are: Spreadtrum Communications, Identive Group, Allos Therapeutics, Flow International, and SuperMedia. The top after-market NASDAQ stock market losers are: Energy Recovery, Marvell Technology Group, Dot Hill Systems, BSQUARE, and EV Energy Partners.

Post-Market NASDAQ Movers (TUES, RVSN, SPPI, SWKS, CVVT, SIFY, REDF, WGOV, ACTG, MSHL)

The top after-market NASDAQ stock market gainers are: Tuesday Morning, Radvision, Spectrum Pharmaceuticals, Skyworks Solutions, and China Valves Technology. The top after-market NASDAQ stock market losers are: Sify Technologies, Rediff.com India, Woodward Governor, Acacia Research, and Marshall Edwards.

A pedestrian walks past the NASDAQ building in New York City

Pre-Market NASDAQ Movers

The top pre-market NASDAQ stock market gainers are: Radvision, Cytori Therapeutics, Allos Therapeutics, Pharmaceutical Product Development, ICAgen, and eBay. The top pre-market NASDAQ stock market losers are: MannKind, F5 Networks, Riverbed Technology, Isle of Capri Casinos, and Skyworks Solutions.

Post-Market NASDAQ Movers (VITA, ALTH, ICGN, BIOD, EBAY, MNKD, FFIV, WSTL, INAP, RVBD)

The top after-market NASDAQ stock market gainers are: Orthovita, Allos Therapeutics, ICAgen, Biodel, and eBay. The top after-market NASDAQ stock market losers are: MannKind, F5 Networks, Westell Technologies, Internap Network Services, and Riverbed Technology.

The Empire State Building is lit up red in recognition of World AIDS Day in New York.

German researchers report possible HIV infection cure

German researchers say they have cured a man of HIV infection that could prove to be a scientific advance but researchers familiar with the work feel it is not necessarily a treatment advance.

Top Pre-Market NASDAQ Gainers (CYTX, SPPI, ZIXI, PWAV, OXPS)

The top pre-market NASDAQ stock market gainers are: Cytori Therapeutics, Spectrum Pharmaceuticals, Zix, Powerwave Technologies, optionsXpress Holdings, Interactive Brokers Group, Qiao Xing Universal Resources, Seagate Technology, and Fifth Third Bancorp.

LYMPHOMA

Pages